Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06779344
NA

MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD

Sponsor: Capital Medical University

View on ClinicalTrials.gov

Summary

This randomized controlled trial will investigate the clinical impact of Myxovirus Resistance A (MxA) and C-Reactive Protein (CRP)-guided antimicrobial treatment compared to usual care in outpatients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Official title: Myxovirus Resistance Protein a and C-Reactive Protein-Guided Antimicrobial Treatment in Outpatients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

458

Start Date

2025-01-13

Completion Date

2026-12-31

Last Updated

2025-01-16

Healthy Volunteers

No

Interventions

OTHER

MxA and CRP tests

A whole blood sample will be collected on the day of randomization for MxA and CRP testing.

OTHER

MxA and CRP feedback

MxA and CRP results will be reported to the attending physcian within 4 hours, along with antimicrobial treatment guidelines based on these results.

OTHER

Follow up

Telephone visit will be conducted on Day 14, Day 30, and Day 90 after randomization. Day 14 and Day 30 follow-up: antimicrobial usage; additional medical visits, hospitalization, death, symptom scores (CAT score and mMRC score). Day 90 follow-up: Occurrence of another exacerbation of COPD, symptom scores (CAT score and mMRC score), death.

Locations (1)

China-Japan Friendship hospital

Beijing, Beijing Municipality, China